Acobiom (Acobiom) is a biotechnology company that specializes in biomarker discovery and development of innovative diagnostics. The company undertakes the discovery of RNA and DNA biomarkers, which finds application in the areas of disease detection, and classification, patient stratification, companion diagnosis and disease prognosis. It develops diagnostics centered on personalized medicine and precision medicine applications. Acobiom also provides services such as sequencing, next generation sequencing (NGS), bioinformatics, biostatistics, real time PCR, and others. The company offers technology platforms such as qRT-PCR, gene expression and bioinformatics. The company provides products in the areas of personalized medicines, medical products, leukemia and gemcitest, among others. Acobiom is headquartered in Montpellier, France.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Acobiom
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Acobiom Company Overview
- Acobiom Company Snapshot
- Acobiom Pipeline Products and Ongoing Clinical Trials Overview
- Acobiom - Pipeline Analysis Overview
- Acobiom - Key Facts
- Acobiom - Major Products and Services
- Acobiom Pipeline Products by Development Stage
- Acobiom Pipeline Products Overview
- Biomarker Test - Hantavirus
- Biomarker Test - Hantavirus Product Overview
- Companion Diagnostic Assay - Masitinib
- Companion Diagnostic Assay - Masitinib Product Overview
- Companion Diagnostic Assay - Prostate Cancer
- Companion Diagnostic Assay - Prostate Cancer Product Overview
- Companion Diagnostic Test - Alzheimer's Disease
- Companion Diagnostic Test - Alzheimer's Disease Product Overview
- Companion Diagnostic Test - Breast Cancer
- Companion Diagnostic Test - Breast Cancer Product Overview
- Companion Diagnostic Test - Lung Cancer
- Companion Diagnostic Test - Lung Cancer Product Overview
- Companion Diagnostic Test - Triple Negative Breast Cancer
- Companion Diagnostic Test - Triple Negative Breast Cancer Product Overview
- Dental Device
- Dental Device Product Overview
- Diagnostic Assay - Chronic Myelomonocytic Leukemia
- Diagnostic Assay - Chronic Myelomonocytic Leukemia Product Overview
- Diagnostic Test - Dengue
- Diagnostic Test - Dengue Product Overview
- Diagnostic Test - Leishmania
- Diagnostic Test - Leishmania Product Overview
- Diagnostic Tool - Left Ventricular Heart Failure
- Diagnostic Tool - Left Ventricular Heart Failure Product Overview
- Diagnostic/Prognostic Assay - Alzheimer's Disease
- Diagnostic/Prognostic Assay - Alzheimer's Disease Product Overview
- Diagnostic/Prognostic Assay - Breast Cancer
- Diagnostic/Prognostic Assay - Breast Cancer Product Overview
- Diagnostic/Prognostic Assay - Lung Cancer
- Diagnostic/Prognostic Assay - Lung Cancer Product Overview
- Diagnostic/Prognostic Assay - Pancreatic Cancer
- Diagnostic/Prognostic Assay - Pancreatic Cancer Product Overview
- Screening Device - Bipolar Disorder
- Screening Device - Bipolar Disorder Product Overview
- Acobiom - Key Competitors
- Acobiom - Key Employees
- Acobiom - Locations And Subsidiaries
- Head Office
- Recent Developments
- Acobiom, Recent Developments
- Oct 21, 2021: A 20-year expertise in omics services and pharmacogenomics analysis
- Nov 21, 2019: Acobiom announces the CE marking of GemciTest
- Nov 03, 2012: Skuldtech And AB Science Announce Identification Of New Predictive Markers For Pancreatic Cancer Survival Associated With Masitinib Treatment
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Acobiom Pipeline Products and Ongoing Clinical Trials Overview
- Acobiom Pipeline Products by Equipment Type
- Acobiom Pipeline Products by Indication
- Acobiom, Key Facts
- Acobiom, Major Products and Services
- Acobiom Number of Pipeline Products by Development Stage
- Acobiom Pipeline Products Summary by Development Stage
- Biomarker Test - Hantavirus - Product Status
- Biomarker Test - Hantavirus - Product Description
- Companion Diagnostic Assay - Masitinib - Product Status
- Companion Diagnostic Assay - Masitinib - Product Description
- Companion Diagnostic Assay - Prostate Cancer - Product Status
- Companion Diagnostic Assay - Prostate Cancer - Product Description
- Companion Diagnostic Test - Alzheimer's Disease - Product Status
- Companion Diagnostic Test - Alzheimer's Disease - Product Description
- Companion Diagnostic Test - Breast Cancer - Product Status
- Companion Diagnostic Test - Breast Cancer - Product Description
- Companion Diagnostic Test - Lung Cancer - Product Status
- Companion Diagnostic Test - Lung Cancer - Product Description
- Companion Diagnostic Test - Triple Negative Breast Cancer - Product Status
- Companion Diagnostic Test - Triple Negative Breast Cancer - Product Description
- Dental Device - Product Status
- Dental Device - Product Description
- Diagnostic Assay - Chronic Myelomonocytic Leukemia - Product Status
- Diagnostic Assay - Chronic Myelomonocytic Leukemia - Product Description
- Diagnostic Test - Dengue - Product Status
- Diagnostic Test - Dengue - Product Description
- Diagnostic Test - Leishmania - Product Status
- Diagnostic Test - Leishmania - Product Description
- Diagnostic Tool - Left Ventricular Heart Failure - Product Status
- Diagnostic Tool - Left Ventricular Heart Failure - Product Description
- Diagnostic/Prognostic Assay - Alzheimer's Disease - Product Status
- Diagnostic/Prognostic Assay - Alzheimer's Disease - Product Description
- Diagnostic/Prognostic Assay - Breast Cancer - Product Status
- Diagnostic/Prognostic Assay - Breast Cancer - Product Description
- Diagnostic/Prognostic Assay - Lung Cancer - Product Status
- Diagnostic/Prognostic Assay - Lung Cancer - Product Description
- Diagnostic/Prognostic Assay - Pancreatic Cancer - Product Status
- Diagnostic/Prognostic Assay - Pancreatic Cancer - Product Description
- Screening Device - Bipolar Disorder - Product Status
- Screening Device - Bipolar Disorder - Product Description
- Acobiom, Key Employees
- Glossary
- Acobiom Pipeline Products by Equipment Type
- Acobiom Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BioSystems International
- Applied Biosystems France SA
- GenoSplice technology SARL
- Firalis SAS
